Research Area
Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure
Research Title
A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure
Introduction
Heart failure (HF) is one among the most prevalent chronic illnesses with a profound clinical and economic impact on society. Previously, researchers have concentrated on the systolic dysfunction to explain the clinical features of HF. Consequently, treatment strategies such as preload and afterload reduction or the use of diuretic agents have been established for patients with reduced systolic left ventricular function. More
recently, it has been determined that systolic and diastolic dysfunctions coexist in the majority of patients with congestive HF. N Terminal pro BNP (NT pro BNP) is a cardiac neurohormone that is secreted from the myocardium in response to increased intracardiac pressure or volume.
Abstract
The purpose of this study was to evaluate whether yoga training in addition to standard medical therapy can improve cardiac function and reduce N terminal pro B-type natriuretic peptide (NT pro BNP) in heart failure (HF).
Conclusion
Results of this study demonstrate that a 12 week yoga therapy in addition to standard medical therapy improves cardiac function and myocardial stress in patients with stable HF. The improvement in cardiac function and myocardial stress seems
to translate into a lower mortality rate. The clinical implication is that moderate physical activity in the form yoga asana, pranayama, and relaxation may be recommended in conjunction with standard medical therapy in stable HF patients.
